Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Laser Therapy × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Other hematologic neoplasm 1 Other 1 Gynecologic 1 Breast 1

Conditions

Mucositis 1 Hematologic Neoplasms 1

Interventions

naloxegol 5 Metformin 4 alvimopan 3 Radiotherapy 3 tegaserod 2 Testosterone Propionate 2 Surveys and Questionnaires 2 Standard of Care 2 Liraglutide 2 Glutamine 2 Fibroblast Growth Factor 7 2 Exenatide 2 Early Intervention, Educational 2 semaglutide 1 prucalopride 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 lime 1 dapagliflozin 1 cyclohexaneacetic acid 1 bicalutamide 1 acetaminophen, hydrocodone drug combination 1 Testosterone 1 Taxes 1 Tamoxifen 1 Tadalafil 1 Sugars 1 Sugammadex 1 Sucralfate 1 Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02696408 2020-01-29

STOP MUCITES

Institut de Cancérologie de la Loire

Phase 3 Completed

OtherOther hematologic neoplasm

Hematologic Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡